Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine

An orally active vaccine capable of boosting SARS-CoV-2 immune responses in previously infected or vaccinated individuals would help efforts to achieve and sustain herd immunity. Unlike mRNA-loaded lipid nanoparticles and recombinant replication-defective adenoviruses, replicating vesicular stomatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Kah-Whye, Carey, Timothy, Lech, Patrycja, Vandergaast, Rianna, Muñoz-Alía, Miguel Á., Packiriswamy, Nandakumar, Gnanadurai, Clement, Krotova, Karina, Tesfay, Mulu, Ziegler, Christopher, Haselton, Michelle, Sevola, Kara, Lathrum, Chase, Reiter, Samantha, Narjari, Riya, Balakrishnan, Baskar, Suksanpaisan, Lukkana, Sakuma, Toshie, Recker, Jordan, Zhang, Lianwen, Waniger, Scott, Russell, Luke, Petro, Christopher D., Kyratsous, Christos A., Baum, Alina, Janecek, Jody L., Lee, Rachael M., Ramachandran, Sabarinathan, Graham, Melanie L., Russell, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743387/
https://www.ncbi.nlm.nih.gov/pubmed/35282925
http://dx.doi.org/10.1016/j.vaccine.2021.12.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743387/
https://www.ncbi.nlm.nih.gov/pubmed/35282925
http://dx.doi.org/10.1016/j.vaccine.2021.12.063

Ejemplares similares